¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Hepatitis B Vaccine Recombinant"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® vaccine ÇÑ±Û ¹é½Å
¼³¸í   
  Àü¿°º´¿¡ ´ëÇÏ¿© ÀΰøÀûÀ¸·Î ¸é¿ªÀ» ÁÖ±â À§ÇØ »ýü¿¡ Åõ¿©Çϴ Ç׿øÀÇ Çϳª. º´¿øÃ¼ ¹× µ¶¼Ò¿¡ ´ëÇÑ ¹æ¾î±â±¸¸¦ °­È­ÇÒ ¸ñÀûÀ¸·Î »ç¿ëµÇ´Â ¹Ì»ý¹°Á¦Á¦¸¦ ¸»ÇÑ´Ù. ÇÁ¶û½ºÀÇ ¹Ì»ý¹°ÇÐÀÚ L. ÆÄ½ºÅ𸣿¡ ÀÇÇÏ¿© Á¦Ã¢µÈ ¿ë¾î·Î¼­, ¾î¶² °¨¿°Áõ¿¡ ´ëÇÏ¿© ÀΰøÀûÀ¸·Î ¸é¿ªÀ» ¾ò±â À§ÇÏ¿© ±× º´¿ø ¹Ì»ý¹° ¶Ç´Â ±× µ¶¼Ò¾×¿¡ Àû´çÇÑ Á¶ÀÛÀ» °¡ÇÏ¿© ¸¸µç °ÍÀ» ¸»ÇÑ´Ù.
¿µ¹® hepatitis ÇÑ±Û °£¿°
¼³¸í   
  °£¿¡ »ý±â´Â ¿°ÁõÀ» ÅëÆ²¾î À̸£´Â ¸». ¹ß¿­-Ȳ´Þ-Àü½Å±ÇÅÂ-¼ÒÈ­ Àå¾ÖÀÇ Áõ»óÀ» º¸À̴µ¥, ÁֵȠ¿øÀÎÀº À½½Ä¹°°ú Ç÷¾×À» ÅëÇÑ ¹ÙÀÌ·¯½º °¨¿°À̸砱נ¹Û¿¡ ¾à¹°, ¾ËÄÚ¿Ã, ¾Ë·¹¸£±â µîÀÌ ¿øÀÎÀΠ°Íµµ ÀÖ´Ù. ÀÌ °£¿°Àº ±× Áö¼Ó±â°£¿¡ µû¶ó¼­ ±Þ¼º°£¿°°ú ¸¸¼º°£¿°À¸·Î ³ª´©´Âµ¥, ¸¸¼º°£¿°Àº 6°³¿ù À̻󠰣¿°ÀÌ Áö¼ÓµÇ´Â °æ¿ì¸¦ ¸»ÇÏ°í ±Þ¼º°£¿°Àº 6°³¿ù ÀÌ»ó Áö¼ÓÇÏÁö ¸øÇϴ °æ¿ì¸¦ ¸»ÇÑ´Ù. ±Þ¼º°£¿°Àº ¸·¿¬ÇÑ ¸íĪÀ¸·Î¼­, °£ÀÇ ±Þ¼º-½ÇÁú¼º »óÇØÀÇ °ÅÀÇ ÀüºÎ¸¦ Æ÷°ýÇϴ ³ÐÀº °³³äÀÌÁö¸¸, ½ÇÁ¦´Â ¹ÙÀÌ·¯½ºÀÇ °¨¿°À¸·Î »ý±â´Â °£¿°ÀÌ ´ëºÎºÐÀÌ´Ù. ¹ÙÀÌ·¯½º¼º °£¿°Àº À¯Ç༱°£¿°(AÇü)°ú Ç÷û°£¿°(BÇü)ÀÇ µÎ Á¾·ù°¡ Àִµ¥, À̵éÀº ¸ðµÎ Àü¿°¼º ÁúȯÀÌÁö¸¸ °¨¿° °æ·Î´Â ´Ù¸£´Ù. °¨¿° °æ·Î·Î À¯Ç༱°£¿°¹ÙÀÌ·¯½º´Â Ç÷¾×-»ùâÀÚ¾×-´ëº¯ Áß¿¡¼­ Áõ¸íµÇ¹Ç·Î Àü¿°µÈ ¹°-À½½ÄÀ» ÅëÇÏ¿© °æ±¸°¨¿°µÇ°Å³ª È¯ÀÚ¿ÍÀÇ Á÷Á¢ Á¢ÃË¿¡ ÀÇÇØ¼­ °¨¿°µÈ´Ù. Ç÷û°£¿°Àº ¿À·ÎÁö ºñ°æ±¸Àû °¨¿°À¸·Î È¯ÀÚÀÇ Ç÷û, Ç÷¾×ÀÇ ÁÖ»ç, È¯ÀÚÀÇ Ç÷¾×¿¡ °¨¿°µÈ ÁÖ»ç±â µîÀ¸·Î °¨¿°µÈ´Ù. Àẹ±â´Â À¯Ç༺°£¿°ÀÌ 2~6ÁÖ°£À̰í, Ç÷û °£¿°Àº 6ÁÖ~6°³¿ù °¡·® µÈ´Ù. Ç÷û°£¿°Àº À¯ÇàÀÇ °èÀý-¿¬·É°ú´Â °ü°è°¡ ¾øÀ¸³ª, À¯Ç༺°£¿°Àº ÁַΠ°¡À»¿¡¼­ °Ü¿ï¿¡ °ÉÃÄ ¸¹°í Ã»¼Ò³â¿¡ ¸¹´Ù. Áõ¼¼´Â ¹ßº´Çϱâ 1ÁÖÀÏ ÀüºÎÅÍ ¿Â¸öÀÌ ³ë°ïÇÏ°í ½Ä¿åÀÌ ¶³¾îÁö¸ç µÎÅëÀÌ ÀÖ°í »óº¹ºÎ¿¡ ºÒÄè°¨ÀÌ »ý±â´Âµ¥, À¯Ç༺°£¿°¿¡¼­´Â È²´ÞÀÌ ³ªÅ¸³ª±â Àü¿¡ ¹ß¿­(38¡É ÀüÈÄ)ÀÌ ÀÖÀ» ¶§°¡ ¸¹°í ¼öÀÏ ÈÄ¿¡ ÇØ¿­µÈ´Ù. ¶Ç, °üÀý-Ç㸮°¡ ¾ÆÇà¶§µµ ÀÖ¾î Ã³À½¿¡´Â °¨±â·Î ¿ÀÀÎÇÒ ¶§°¡ ¸¹´Ù. Ç÷û°£¿°Àº ÀÌ·¯ÇÑ Ãʱâ Áõ¼¼°¡ °¡º±°í ¼­¼­È÷ ¹ßº´Çϴ °ÍÀÌ ¸¹´Ù. ÁÖÁõ¼¼´Â À§ÀåÁõ¼¼¿Í È²´ÞÀ̸ç, ½Ä¿åºÎÁø-±¸Åä-±¸¿ªÁú, »óº¹ºÎÀÇ µÐÅë µîÀÌ ÀϾ¸ç, ¹ßº´ ÈÄ 4~5ÀÏ¿¡ È²´ÞÀÌ ³ªÅ¸³­´Ù. È²´ÞÀº 1ÁÖÀÏÀ» ÀüÈÄÇÏ¿© ÃÖ°í¿¡ À̸£¸ç, ±× ÈÄ 1°³¿ù »çÀÌ¿¡ ¾ø¾îÁö¸é¼­ ´Ù¸¥ Áõ¼¼µµ ÁÁ¾ÆÁø´Ù. °æ°ú´Â ±Þ¼º°£¿°Àº ¾à 70%°¡ ´ë°³ 1~3°³¿ù À̳»¿¡ Ä¡À¯µÇÁö¸¸ »¡¸® Ä¡·áµÇÁö ¾Ê´Â °Í Áß 15%°¡ ¸¸¼º°£¿°À¸·Î ÀÌÇàÇϸç, ±× ÀϺδ °£°æÈ­ÁõÀ¸·Î ÀÌÇàÇÑ´Ù. ±Þ¼º°£¿° Áß¿¡´Â ¶§·Î´Â 10ÀÏ À̳»¿¡ »ç¸ÁÇϴ Àü°Ý¼º°£¿°À̶ó°í Çϴ °Íµµ ÀÖ´Ù. º´ÀÇ Àüü °æ°ú ÁߠȲ´ÞÀÌ ³ªÅ¸³ªÁö ¾Ê´Â ¹«È²´Þ¼º °£¿°À̶ó°í Çϴ °Íµµ ÀÖ¾î. ¸¸¼º°£¿°À¸·Î ÀÌÇàÇϴ °Í¿¡´Â ÀÌ ¹«È²´Þ¼ºÀÌ ¸¹Àº °æÇâÀÌ ÀÖ´Ù. Ç÷û°£¿°µµ ¸¸¼ºÈ­Çϱ⠽±´Ù.
¿µ¹® acute hepatitis ÇÑ±Û ±Þ¼º°£¿°
¼³¸í   
  ¹ÙÀÌ·¯½º¿¡ ÀÇÇØ °£¿¡ »ý±â´Â ±Þ¼º¿°Áõ. ±Þ¼º°£¿°À̶õ °£¿°¹ÙÀÌ·¯½º(AÇü-BÇü-ºñAºñBÇü)¿¡ ÀÇÇØ¼­ °£¿¡ »ý±â´Â ±Þ¼º¿°ÁõÀ» º´¸íÀ¸·Î À̸£´Â ¸»·Î, À̴ ±× °¨¿°¾ç½Ä¿¡ ¼öÇ÷ ÈÄ¿¡ ¹ß»ýÇϴ ¼öÇ÷ÈÄ °£¿°°ú, °¨¿°°æ·Î¸¦ ¾Ë ¼ö ¾ø´Â »ê¹ß¼º°£¿° ¹× Áý´ÜÀ¸·Î ¹ß»ýÇϴ À¯Ç༱°£¿°ÀÇ ¼¼°¡Áö À¯ÇüÀ¸·Î ³ª´­ ¼ö ÀÖ´Ù. ¼öÇ÷ÈÄ °£¿°Àº ±× 95%°¡ ºñAºñBÇü°£¿°À̸砳ª¸ÓÁö°¡ BÇü °£¿°ÀÌ´Ù. »ê¹ß¼º °£¿°Àº AÇü °£¿°°ú BÇü °£¿°ÀÌ °¢°¢ 30%¸¦ ÀÌ·ç°í ³ª¸ÓÁö 40%´Â ºñAºñB°£¿°ÀÌ´Ù. Áý´ÜÀ¸·Î ¹ß»ýÇϴ À¯Ç༺°£¿°Àº °ÅÀǰ¡ AÇü°£¿°ÀÌÁö¸¸ ¶§·Î´Â ¿©±â¿¡ Æ÷ÇÔµÇÁö ¾ÊÀº ÇüÀÇ °£¿°ÀÏ °æ¿ìµµ ÀÖ´Ù. ±Þ¼º°£¿°ÀÇ Áõ¼¼´Â ¸ÕÀú ¸öÀÌ ³ª¸¥ÇØÁö°í ¿Â¸ö¿¡ ±ÇۨÀ̠ã¾Æ¿À¸ç Á¶±×¸¶ÇÑ ÀÏ¿¡µµ °ð ÇǷθ¦ ´À³¢°Ô µÈ´Ù. ±×¸®°í ½Ä¿åºÎÁø-¹ß¿­-±¸ÅäÁõ-º¹Åë-¼³»ç µî, °¨±â³ª ±Þ¼ºÀ§Àå¿°¿¡ °É·ÈÀ» ¶§¿Í °°Àº Áõ¼¼ µîÀÌ ³ªÅ¸³­´Ù. µÚÀ̾î È²´ÞÁõ¼¼¸¦ º¸À̴µ¥, À̶§´Â ÃʱâÀÇ Áõ¼¼°¡ ¾à°£ °¡º­¿öÁø °Íó·³ ´À²¸Áö´Â °ÍÀÌ º¸ÅëÀÌ´Ù. ±×·¯³ª È²´ÞÁõ¼¼°¡ ½ÉÇØÁö°í ÃʱâÀÇ Áõ¼¼µéÀÌ ´Ù½Ã ÁøÇàµÇ¸é À̶§´Â Àü°Ý¼º°£¿°ÀÌ µÉ À§ÇèÀÌ ÀÖ´Ù. °£¿° Áõ¼¼°¡ ½ÉÇÏÁö ¾Ê¾ÒÀ» °æ¿ì´Â È²´ÞÀÌ ´«¿¡ ¶çÁö ¾ÊÀº °æ¿ìµµ Àִµ¥ À̶§´Â ÁøÂûÀ» Çصµ °¨±â³ª ±Þ¼ºÀ§Ã¢ÀÚ¿°À¸·Î ÀÚÄ© ¿ÀÁøµÇ±â ½±´Ù. ¶Ç AÇü°£¿°Àº ¿­ÀÌ 38~39¡É±îÁö ¿À¸£°í Áõ¼¼°¡ °©Àڱ⠳ªÅ¸³ª´Â °ÍÀ̠Ư¡À̸砱޼ººñAºñBÇü°£¿°Àº Áõ¼¼°¡ ºñ±³Àû °¡º­¿î °ÍÀ̠Ư¡ÀÌ´Ù. ±Þ¼ºBÇü°£¿°ÀÇ Áõ¼¼´Â AÇü°£¿°°ú ±Þ¼ººñAºñBÇü°£¿°ÀÇ Áß°£ Á¤µµÀΠ°ÍÀÌ º¸ÅëÀÌ´Ù.
¿µ¹® chronic active hepatitis ÇÑ±Û ¸¸¼ºÈ°µ¿°£¿°
¼³¸í   
  BÇü °£¿°À̳ª ºñAÇü£­ºñBÇü °£¿°ÀÇ ¼Ó¹ßÁõÀ¸·Î ³ªÅ¸³ª´Â °£ÀÇ ¸¸¼º¿°ÁõÀÌ´Ù. °°Àº ÇüÅÂÀÇ º´ÀÌ ¼±Ãµ¼º ¶Ç´Â ÈÄõ°¨¸¶±Û·ÎºÒ¸°°áÇÌÁõÀ̳ª ¾î¶² Á¾·ùÀÇ ¾à¹° Åõ¿©¿¡ ¼ö¹ÝÇØ¼­ ³ªÅ¸³¯ ¼öµµ ÀÖ´Ù. Æ¯Â¡ÀûÀ¸·Î ¹®¸ÆºÎ¿¡ ÇüÁú¼¼Æ÷¿Í Å«Æ÷½Ä¼¼Æ÷ÀǠħÀ±, Á¶°¢±«»ç(°£¼Ò¿± ÁÖº¯ºÎ °£¼¼Æ÷ÀÇ ÆÄ±«) ¹× ¼¶À¯Áõ µîÀÇ Á¶Á÷¼Ò°ßÀ» ³ªÅ¸³½´Ù. º´ÀÇ °æ°ú´Â ¸Å¿ì ´Ù¾çÇϸç Àå±â°£ÀÇ ¹«Áõ»ó±â¸¦ º¸ÀÏ ¼öµµ ÀÖ°í ±× »çÀÌ »çÀÌ¿¡ È²´Þ, Àü½Å¼è¾à, ½Ä¿åºÎÁø ¹× ¹ß¿­ µîÀÇ Áõ»óÀÌ ³ªÅ¸³ª´Â ¼ö°¡ ÀÖÀ¸¸ç, ¶Ç ¹«¿ù°æÁõ, °üÀý¿°, ÇǺιßÁø, Ç÷°ü¿°, °©»ó»ù¿°, ÄáÆÏ»ç±¸Ã¼¿°, ±Ë¾ç¼º´ëÀå¿°, ½¦±×·»ÁõÈıº µî °£ ÀÌ¿ÜÀÇ Áõ»óÀÌ ³ªÅ¸³ª´Â ¼öµµ ÀÖ°í, °£°æÈ­Áõ°ú °£±â´É»ó½Ç·Î ÁøÇàµÇ´Â ¼öµµ ÀÖ´Ù. ÀÚ°¡¸é¿ª¸ÞÄ¿´ÏÁòÀÌ °ü¿©µÇ´Â °ÍÀ¸·Î ÃßÃøµÇ°í ÀÖ´Ù.
¿µ¹® fulminant hepatitis ÇÑ±Û Àü°Ý°£¿°
¼³¸í   
  ¹ÙÀÌ·¯½º °£¿°ÀÇ ÇÑ ÇüÀ¸·Î ±Þ¼º È²»öÀ§ÃàÁõÀ̶ó°íµµ ºÎ¸¥´Ù. °£¼¼Æ÷ÀÇ ´ëºÎºÐÀÌ ±«»ç»óÅ·ΠµÇ¸ç È¯Àڴ º¸Åë »ç¸ÁÇÑ´Ù. È²´ÞÀÌ ³ªÅ¸³ª±â ÀüºÎÅÍ À̹̠Áõ»óÀº ÇöÀúÈ÷ ÁøÇàÇÏ¿© È²´ÞÀÇ ÃâÇöµµ ºü¸£°í, ±Þ¼º ¹ß¿­À» ¼ö¹ÝÇϸç Á¡¸·À̳ª ÇÇÇÏÃâÇ÷À» º¼ ¼ö ÀÖ´Ù. °£ÀÇ ¾ÐÅëÀ» ¼ö¹ÝÇϴ ¼öµµ ÀÖ´Ù. À§Ãà¿¡ ÀÇÇÏ¿© °£Àº ÀÚÁÖ ÀÛ¾ÆÁø´Ù. ÃÖÈÄ¿¡´Â ÀǽÄÀå¾Ö¸¦ ÃÊ·¡ÇÏ¿© Á¹À½ÀÌ ¿À°í È¥¹Ì»óÅ·ΠµÇ¸ç °£¼ºÈ¥¼ö·Î ÁøÇàÇÏ¿© »ç¸ÁÇϰԠµÈ´Ù. Áõ»óÀÌ ½ÃÀ۵Ǿî 2~3ÁÖ ³»¿¡ °£³úº´Áõ±îÁö ÁøÇàÇϴ °£±â´É »ó½ÇÀ» Àü°Ý¼º °£±â´É»ó½ÇÀ̶ó°í ºÎ¸£¸ç, ÁøÇà ¼Óµµ°¡ ºü¸£Áö ¾Ê¾Æ¼­ 3°³¿ù¿¡ À̸£·¯ °£±â´É»ó½Ç¿¡ ºüÁö´Â °ÍÀº ¾Æ±Þ¼º °£±â´É»ó½ÇÀ̶ó°í ºÎ¸¥´Ù. ¸ðµç °£¿° ¹ÙÀÌ·¯½º°¡ ¸ðµÎ ÀÏÀ¸Å°Áö´Â ¾Ê´Â´Ù. °£¿°A¹ÙÀÌ·¯½º¿Í °£¿°E¹ÙÀÌ·¯½º´Â º¸À¯ÀÚ »óųª ¸¸¼º °£¿°À» °ÅÀÇ ÀÏÀ¸Å°Áö ¾Ê´Â´Ù. ±âŸ ´Ù¸¥ °¨¿° ¶Ç´Â ºñ°¨¿°¼º ¿øÀÎ, Æ¯È÷ ¾à¹°°ú µ¶¼Òµµ º»ÁúÀûÀ¸·Î µ¿ÀÏÇÑ ÁõÈĸ¦ ÀÏÀ¸Å³ ¼ö ÀÖ´Ù. ±×·¯¹Ç·Î ¹ÙÀÌ·¯½º¼º °£¿°ÀÇ Áø´Ü°ú °¢ °£¿° ¹ÙÀÌ·¯½º¸¦ ±¸º°Çϴµ¥´Â Ç÷ûÇÐÀû °Ë»ç°¡ ÇʼöÀûÀÌ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • recombinant vaccine
    ÀçÁ¶ÇÕ¹é½Å
  • hepatitis B vaccine
    BÇü°£¿°¹é½Å
  • recombinant
    1. ÀçÁ¶ÇÕü-, ÀçÁ¶ÇÕ- 2. ÀçÁ¶ÇÕÇü- 3. ÀçÁ¶ÇÕü 4. ÀçÁ¶ÇÕÇü
  • recombinant antigen
    ÀçÁ¶ÇÕÇ׿ø
  • recombinant chromosome
    ÀçÁ¶ÇÕ¿°»öü
  • recombinant DNA technology
    ÀçÁ¶ÇÕDNA±â¼ú
  • attenuated vaccine
    ¾à(µ¶)È­¹é½Å, ¾àµ¶¹é½Å
  • human diploid cell vaccine
    »ç¶÷µÎ¹è¼ö¼¼Æ÷¹é½Å
  • inactivated vaccine
    ºÒȰ¼ºÈ­¹é½Å, ºñµ¿È­¹é½Å
  • killed vaccine
    »ç¸ê¹é½Å, »ç¹é½Å
  • live vaccine
    »ý¹é½Å
  • mixed vaccine
    È¥ÇÕ¹é½Å
  • rabies vaccine
    ±¤°ßº´¹é½Å
  • subunit vaccine
    ¾Æ´ÜÀ§¹é½Å
  • vaccine
    ¹é½Å
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • recombinant antigen
    ÀçÁ¶ÇÕÇ׿ø
  • recombinant
    ÀçÁ¶ÇÕü, ÀçÁ¶ÇÕ±ÕÁÖ, ÀçÁ¶ÇÕÇü
  • hepatitis
    °£¿°
  • acute hepatitis
    ±Þ¼º°£¿°
  • neonatal hepatitis
    ½Å»ý¾Æ°£¿°
  • serum hepatitis
    Ç÷û°£¿°
  • viral hepatitis
    ¹ÙÀÌ·¯½º°£¿°
  • vaccine
    ¹é½Å
  • attenuated vaccine
    µ¶¼º¾àÈ­¹é½Å, ¾àµ¶¹é½Å
  • diphteria and tetanus toxoids and acellular pert vaccine
    °³·®µðÇÇÆ¼
  • inactivated vaccine
    ºÒȰ¼ºÈ­¹é½Å, ºñµ¿È­¹é½Å
  • killed vaccine
    »ç¸ê¹é½Å, »ç¹é½Å
  • live vaccine
    »ý¹é½Å
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • recombinant vaccine
    ÀçÁ¶ÇÕ¹é½Å
  • recombinant antigen
    ÀçÁ¶ÇÕÇ׿ø
  • recombinant
    ÀçÁ¶ÇÕü, ÀçÁ¶ÇÕ±ÕÁÖ, ÀçÁ¶ÇÕÇü
  • attenuated vaccine
    µ¶¼º¾àÈ­¹é½Å, ¾àµ¶¹é½Å
  • corresponding vaccine
    µ¿Á¾±Õ¹é½Å
  • vaccine exanthem
    Á¾µÎ¹ßÁø
  • inactivated vaccine
    ºÒȰ¼ºÈ­¹é½Å, ºñµ¿È­¹é½Å
  • internal image vaccine
    ³»ºÎ¿µ»ó¹é½Å, °³º°Æ¯ÀÌÇü¹é½Å
  • killed vaccine
    »ç¸ê¹é½Å
  • live vaccine
    »ý¹é½Å
  • live vaccine virus
    »ý¹é½Å¹ÙÀÌ·¯½º
  • mixed vaccine
    È¥ÇÕ¹é½Å
  • vaccine rash
    ¹é½Å¹ßÁø
  • subunit vaccine
    ¾Æ´ÜÀ§¹é½Å
  • vaccine therapy
    ¹é½Å¿ä¹ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • recombinant vaccine
    ÀçÁ¶ÇÕ¹é½Å.
  • DNA, recombinant
    ÀçÁ¶ÇÕ DNA
  • recombinant
    Àç°áÇÕÀÇ
  • recombinant
    ˍ禂͟.
  • recombinant
    ÀçÁ¶ÇÕ±ÕÁÖ
  • recombinant DNA
    ÀçÁ¶ÇÕ DNA
  • recombinant antigen
    ÀçÁ¶ÇÕ Ç׿ø
  • BCG vaccine
    ºñ½ÃÁö¹é½Å
  • Bacillus Calmette Gue rin vaccine =BCG v.
    BCG ¹é½Å.
  • Coxs vaccine
    ÄÛ½º¿ÎÁø<¹é½Å>
  • DP vaccine
    µðÇǹé½Å
  • DPT vaccine
    µðÇÇÆ¼¹é½Å
  • DTP vaccine
    µðƼÇǹé½Å
  • Sabin vaccine
    ¼¼À̺ó¹é½Å
  • Sabins vaccine
    ¼¼À̺ó¹é½Å.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • recombinant vaccine
    ÀçÁ¶ÇÕ¹é½Å.
  • recombinant
    Àç°áÇÕÀÇ
  • recombinant
    ÀçÁ¶ÇÕ±ÕÁÖ
  • recombinant
    ˍ禂͟.
  • recombinant DNA
    ÀçÁ¶ÇÕ DNA
  • recombinant antigen
    ÀçÁ¶ÇÕ Ç׿ø
  • anthrax vaccine
    źÀú¹é½Å.
  • antismallpox vaccine
    ¸¶¸¶¹é½Å.
  • attenuated vaccine
    µ¶¼º¾àÈ­¹é½Å.
  • attenuated vaccine
    ¾àµ¶[È­]¹é½Å
  • attenuated vaccine
    µ¶¼º¾àÈ­¹é½Å.
  • bacterial vaccine
    ¼¼±Õ¼º ¿ÎÁø<¹é½Å>.
  • cholera vaccine
    ÄÝ·¹¶ó¹é½Å
  • combined vaccine
    È¥ÇÕ(ûèùê)¿ÎÁø.
  • combined vaccine
    º¹ÇÕ¹é½Å
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • amebic hepatitis
    ¾Æ¸Þ¹Ù°£¿°
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hepatitis B surface antigen
    BÇü(úþ) °£¿°(ÊÜæú) Ç¥¸é Ç׿ø(øúØüù÷ê«)
  • type A hepatitis
    AÇü(úþ) °£¿°(ÊÜæú)
  • type B hepatitis
    BÇü(úþ) °£¿°(ÊÜæú)
  • viral hepatitis
    ¹ÙÀÌ·¯½º¼º °£¿° (ÊÜæú)
  • recombinant
    ÀçÁ¶ÇÕü(î¢ðÚùêô÷)
  • recombinant DNA technique
    ÀçÁ¶ÇÕ(î¢ðÚùê) DNA ¼ú(âú)
  • recombinant joint
    ÀçÁ¶ÇÕ Á¢ÇÕºÎ(î¢ðÚùêïÈùêÝ»)
  • recombinant RNA technique
    ÀçÁ¶ÇÕ(î¢ðÚùê) RNA ¼ú(âú)
  • triparental recombinant
    »ïÁ¶ º¹ÇÕü(ß²ðÓÜÜùêô÷)
  • autogenous vaccine
    ÀÚ°¡(í»Ê«)¹é½Å
  • inactivated vaccine
    ºÒȰ¼ºÈ­(ÝÕüÀàõûù) ¹é½Å
  • live vaccine
    »ý(ßæ)¹é½Å
  • mixed vaccine
    È¥¼º(ûèà÷)¹é½Å
  • multivalent vaccine
    ´Ù°¡(Òýʤ) ¹é½Å
  • polyvalent vaccine
    ´Ù°¡(Òýʤ) ¹é½Å
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • vaccine
    ¹é½Å, ¿ÎÁø
  • fulminant hepatitis
    Àü°Ý¼º°£¿°
  • hepatitis
    °£¿°
  • hepatitis B virus
    BÇü °£¿°¹ÙÀÌ·¯½º
  • infectious hepatitis virus
    Àü¿°¼º°£¿°¹ÙÀÌ·¯½º
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HBV hepatitis B vaccine; hepatitis B virus
AH abdominal hysterectomy; absorptive hypercalciuria; accidental hypothermia; acetohexamide; acid hydro...
rBCG recombinant bacille Calmette-Guerin [vaccine]
YDV yeast-derived hepatitis B vaccine
CAH chronic active hepatitis; chronic aggressive hepatitis; combined atrial hypertrophy; congenital adre...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
r-HBsAg recombinant hepatitis B surface antigen
BPV Bordatella pertussis vaccine
DTP Diphtheria-tetanus-pertussis vaccine
Hib Haemophilus influenzae type b vaccine
HDCV Human Diploid Cell Vaccine
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • recombinant plasminogen activator
    ÀçÁ¶ÇÕ Çö󽺹̳ë°Õ Ȱ¼ºÁ¦
  • acute hepatitis
    ±Þ¼º °£¿°
    ÀÌ º´¸íÀº ¸·¿¬ÇÑ ¸íĪÀ¸·Î¼­, °£ÀÇ ±Þ¼º¡¤½ÇÁú¼º »óÇØÀÇ °ÅÀÇ ÀüºÎ¸¦ Æ÷°ýÇÏ´Â ³ÐÀº °³³äÀÌÁö¸¸, ½ÇÁ¦´Â ¹ÙÀÌ·¯½ºÀÇ °¨¿°À¸·Î »ý±â´Â °£¿°ÀÌ ´ëºÎºÐÀ̰í, °£µ¶¡¤È­Çоàǰ¡¤ÀǾàǰ µîÀ¸·Î »ý±â´Â Áßµ¶¼º °£¿°µµ ºñ±³Àû ¸¹´Ù. ¹ÙÀÌ·¯½º¼º °£¿°Àº À¯Ç༺ °£¿°
  • cholestatic hepatitis
    ´ãÁó ¿ïü¼º °£¿°, ´ãÁó Á¤Ã¼¼º °£¿°
  • chronic active hepatitis
    ¸¸¼º Ȱµ¿¼º °£¿°
  • chronic hepatitis B
    ¸¸¼º BÇü °£¿°
  • epidemic hepatitis
    À¯Ç༺ °£¿°
  • hepatitis
    °£¿°
    °£ÀÇ ¿°Áõ¼º Áúȯ. °£Àå¿°À̶ó°íµµ ÇÑ´Ù. °£ ÁúȯÀÇ ´ëºÎºÐÀ» Â÷ÁöÇÏ´Â °ÍÀ¸·Î¼­, Å©°Ô ±Þ¼º °£¿°°ú ¸¸¼º °£¿°À¸·Î ³ª´«´Ù. ¡¼±Þ¼º °£¿°¡½ ÀÌ º´¸íÀº ¸·¿¬ÇÑ ¸íĪÀ¸·Î¼­, °£ÀÇ ±Þ¼º, ½ÇÁú¼º »óÇØÀÇ °ÅÀÇ ÀüºÎ¸¦ Æ÷°ýÇÏ´Â ³ÐÀº °³³äÀÌÁö¸¸, ½ÇÁ¦´Â ¹ÙÀÌ·¯½ºÀÇ °¨¿°À¸·Î »ý±â´Â °£¿°ÀÌ ´ëºÎºÐÀ̰í, °£µ¶, È­ÇÐ ¾àǰ, ÀǾàǰ µîÀ¸·Î »ý±â´Â Áßµ¶¼º °£¿°µµ ºñ±³Àû ¸¹´Ù. ¹ÙÀÌ·¯½º¼º °£¿°Àº À¯Ç༺ °£¿°
  • hepatitis A
    AÇü °£¿°
    AÇü °£¿° ¹ÙÀÌ·¯½º¿¡ ÀÇÇÏ¿© ¹ß»ýÇÏ´Â Àü¼¼°èÀûÀ¸·Î ºÐÆ÷µÈ ÀÚ±â ÇÑÁ¤¼º ¹ÙÀÌ·¯½º¼º ÁúȯÀ¸·Î¼­, À§»ý »óŰ¡ ³ª»Ú°í °æÁ¦ ¼öÁØÀÌ ³·Àº Áö¿ª¿¡ ´õ¿í ¸¹ÀÌ ¹ß»ýÇÏ¸ç ºñ°æ±¸Àû °¨¿°µµ °¡´ÉÇϱâ´Â Çϳª °ÅÀÇ ÀüÀûÀ¸·Î ´ëº¯ °æ±¸ °æ·Î¸¦ ÅëÇÏ¿© ÀüÆÄµÇ°í, º¸±ÕÀÚ »óÅ´ »ý±âÁö ¾Ê´Â´Ù. Àẹ ±â°£Àº 15-20ÀϷμ­ Æò±Õ 30ÀÏÀÌ´Ù. ´ë´Ù¼ö ȯÀÚ´Â ÀÓ»ó Áõ¼¼°¡ ¶Ñ·ÇÇÏÁö ¾Ê°Å³ª °æÇÑ °¨±â Áõ»óÀ» ³ªÅ¸³»¸ç Ȳ´ÞÀº ÀÖ´õ¶óµµ ¸Å¿ì °æ¹ÌÇÏ´Ù. ±¤¹üÀ§ÇÑ °£ ±«»ç°¡ ÀϾ ¼ö ÀÖÀ¸³ª BÇü °£¿°¿¡¼­ º¸´Ù´Â ÈξÀ Àû°Ô ³ªÅ¸³­´Ù.
  • hepatitis B
    BÇü °£¿°
    BÇü °£¿° ¹ÙÀÌ·¯½º¿¡ ÀÇÇÑ °£ÀÇ ¿°Áõ¼º ÁúȯÀ¸·Î¼­ Àü¼¼°èÀûÀ¸·Î À¯ÇàÇϸç À¯ÇàÀÌ °¡Àå ³ôÀº Áö¿ªÀº Áß°î°ú µ¿³²¾Æ, »çÇ϶ó ÁÖº¯ ¾ÆÇÁ¸®Ä«, ÅÂÆò¾ç±ºµµÀÇ ´ëºÎºÐ ¹× ¾Æ¸¶Á¸ À¯¿ª µîÀÌ´Ù.
  • hepatitis B virus
    BÇü °£¿° ¹ÙÀÌ·¯½º
    1. BÇü °¨¿° ȯÀÚ¿¡¼­ ¸ðµç ü¾× ³»·Î ¹æÃâµÇ´Â ¹ÙÀÌ·¯½º. 2. »ç¶÷ÀÇ °£¿¡ »ì¸ç, Ç÷û °£¿° µîÀ» ÀÏÀ¸Å°´Â ¹ÙÀÌ·¯½º. HB ¹ÙÀÌ·¯½º¶ó°íµµ ÇÑ´Ù. HBs Ç׿ø, HBc Ç׿ø, HBe Ç׿ø µî ¼¼ Á¾·ùÀÇ Ç׿ø ´Ü¹éÁúÀ» Áö´Ñ ¹ÙÀÌ·¯½ºÀÌ´Ù. ÀÌ °¡¿îµ¥ HBs Ç׿ø¿¡´Â º¹¼öÀÇ Ç׿ø °áÁ¤±â°¡ ÀÖ¾î, ±× ¦¸ÂÃã¿¡ µû¶ó BÇü °£¿° ¹ÙÀÌ·¯½º´Â adr, adw, ayr, aywÀÇ 4°¡Áö ¾ÆÇüÀ¸·Î ³ª´©¾îÁ® ÀÖ´Ù. 1965³â ¹Ì±¹ÀÇ S. ºí·³¹ö±×°¡ ¿À½ºÆ®·¹Àϸ®¾Æ ¿øÁÖ¹ÎÀÇ Ç÷û¿¡¼­ ¹ß°ßÇÏ¿© ´çÃÊ¿¡´Â Ç׿ø¼ºÀÌ ÀÖ´Â ¹°ÁúÀ̶ó°í º¸°í, HB Ç׿ø ¶Ç´Â ¿À½ºÆ®·¹Àϸ®¾Æ Ç׿øÀ̶ó°í ºÒ·¶´Ù. ±× ÈÄ DNA
  • infectious hepatitis virus
    Àü¿°¼º °£¿° ¹ÙÀÌ·¯½º
  • lupoid hepatitis
    ·çÇÁ½º¾ç °£¿°, À¯³¶Ã¢ °£¿°
    ¼Ò±¸Áø»ó º´º¯À» Ư¡À¸·Î ÇÏ´Â À¯À°Á¾ÁõÀÇ °£¿°.
  • neonatal hepatitis
    ½Å»ý¾Æ °£¿°
  • serum hepatitis
    Ç÷û °£¿°
    ¹ÙÀÌ·¯½º¼º °£¿° Áß BÇü °£¿° ¹ÙÀÌ·¯½º¿¡ ÀÇÇÏ¿© °£ÀÌ Ä§ÇØµÇ´Â º´. Áõ¼¼´Â À¯Ç༺ °£¿°°ú º»ÁúÀûÀ¸·Î´Â ´Ù¸¦ ¹Ù°¡ ¾ø´Ù. ´Ù¼Ò ¿Ï¸¸ÇÏ°Ô ½ÃÀÛµÇÁö¸¸ °æ°ú°¡ ±æ°í, ¸¸¼ºÈ­ÀÇ °æÇâµµ °­ÇÏ´Ù. Àẹ±â´Â 60¡­90ÀÏÀε¥, ¼öÇ÷ ÈÄ 20ÀÏ Á¤µµ·Î ³ªÅ¸³ª´Â ¼öµµ ÀÖ´Ù. °¨¿° °æ·Î´Â Ç÷¾× ¹× Ç÷¾×Á¦Á¦
  • viral hepatitis
    ¹ÙÀÌ·¯½º °£¿°, ¹ÙÀÌ·¯½º¼º °£¿°
    ÃÖ¼Ò 5Á¾ÀÇ ¼­·Î ´Ù¸¥ ¹ÙÀÌ·¯½º°¡ ¿øÀÎÀÌ µÇ¸ç ÀÌµé ¹ÙÀÌ·¯½ºÀÇ °¨¿°À¸·Î ÀÎÇÑ °£¿°.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
hepatitis B vaccine <virology> An injectable vaccine, given in three boosters, which offers protection from infection with hepatitis B.
(27 Sep 1997)
recombinant <molecular biology> A cell or an individual with a new combination of genes not found together in either parent, usually applied to linked genes.
(18 Nov 1997)
recombinant clone <molecular biology> Clones containing recombinant DNA molecules.
See: recombinant DNA technologies.
(14 Oct 1997)
recombinant clones Clones containing recombinant DNA molecules.
(12 Dec 1998)
recombinant DNA <molecular biology> Spliced DNA formed from two or more different sources that have been cleaved by restriction enzymes and joined by ligases.
(18 Nov 1997)
recombinant DNA molecules A combination of DNA molecules of different origin that are joined using recombinant DNA technology.
(12 Dec 1998)
recombinant DNA technologies Procedures used to join together DNA segments in a cell-free system (an environment outside a cell ororganism). Under appropriate conditions, a recombinant DNA molecule canenter a cell and replicate there, either autonomously or after it hasbecome integrated into a cellular chromosome.
(09 Oct 1997)
recombinant DNA technology A series of procedures used to join together (recombine) DNA segments. A recombinant DNA molecule is constructed (recombined) from segments from 2 or more different DNA molecules. Under certain conditions, a recombinant DNA molecule can enter a cell and replicate there, autonomously (on its own) or after it has become integrated into a chromosome.
(12 Dec 1998)
recombinant fusion proteins Proteins that are the result of genetic engineering. A regulatory part or promoter of one or more genes is combined with a structural gene. The fusion protein is formed after transcription and translation of the fused gene. This type of fusion protein is used in the study of gene regulation or structure-activity relationships. They might also be used clinically as targeted toxins (immunotoxins).
(12 Dec 1998)
recombinant proteins Proteins prepared by recombinant DNA technology.
(12 Dec 1998)
recombinant strain <molecular biology> A cell or an individual with a new combination of genes not found together in either parent, usually applied to linked genes.
(18 Nov 1997)
recombinant vector A vector into which a foreign DNA has been inserted.
Synonym: vector.
(05 Mar 2000)
clones, recombinant Clones containing recombinant DNA molecules.
(12 Dec 1998)
molecules, recombinant DNA A combination of DNA molecules of different origin that are joined using recombinant DNA technology.
(12 Dec 1998)
somatotropins, recombinant Somatotropin prepared by recombinant DNA technology. Several different forms have been developed from humans, cows, and pigs. They have been used to help stimulate growth.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hepatitis
    °£¿°
  • hepatitis A
    AÇü °£¿°;Àü¿°¼º(Ç÷û)°£¿°
  • recombinant
    (À¯ÀüÀÚ °£ÀÇ)ÀçÁ¶ÇÕÇü(ÀÇ)
  • recombinant DNA
    ÀçÁ¶ÇÕ DNA
  • vaccine
    ¿ìµÎÁ¾
  • Sabin vaccine
    ¼¼À̺ó ¹é½Å(¼Ò¾Æ¸¶ºñ »ý ¹é½Å)
  • Salk vaccine
    ¼ÒÅ©¹é½Å(¼Ò¾Æ¸¶ºñ ¿¹¹æ¿ë)
  • vaccine
    ¿ìµÎÁ¾;¹é½Å
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á